Adma Biologics (ADMA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Dec17

ADMA Biopharmaceuticals CEO Disposes of Ordinary Shares

02:01

Nov6

Adma Biologics released FY2025 Q3 earnings on November 5 After-Market (EST), actual revenue USD 134.22 M (forecast USD 130.53 M), actual EPS USD 0.1499 (forecast USD 0.15)

00:00

Adma Biologics released FY2025 9 Months Earnings on November 5 After-Market EST, actual revenue USD 371.01 M, actual EPS USD 0.3999

00:00

Nov5

ADMA Biologics Raises Full-Year Revenue Guidance

21:06

Oct29

Adma Biologics to release FY2025 Q3 earnings on November 5 After-Market EST, forecast revenue USD 130.53 M, EPS USD 0.15

00:06

Aug14

Nuveen LLC Purchased ADMA Biologics' New Shares in Q1

09:04

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 134.22 M, Net Income 36.43 M, EPS 0.1499

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 121.98 M, Net Income 34.22 M, EPS 0.1399

May7

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 114.8 M, Net Income 26.9 M, EPS 0.11

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change